Finding 1150296 (2023-001)

Material Weakness
Requirement
P
Questioned Costs
-
Year
2023
Accepted
2025-08-19
Audit: 364502
Organization: Basic Health International (PA)

AI Summary

  • Core Issue: A material weakness in internal control was identified, specifically regarding untimely invoicing and inadequate controls over bank reconciliations and cash transactions.
  • Impacted Requirements: Internal controls must ensure timely invoicing and proper oversight of financial processes to prevent misstatements in financial reporting.
  • Recommended Follow-Up: Implement procedures for timely invoicing, thorough reconciliation reviews, and strong controls over cash transactions to address the identified weaknesses.

Finding Text

2023-001 – Material Weakness in internal control Condition: As part of the financial statement audit, a material weakness in internal control was reported related to untimely invoicing under contracts and performance and review of monthly bank and credit card reconciliations, and lack of controls over cash receipts and cash disbursements. Criteria: Internal controls should be in place that provide reasonable assurance that invoicing will occur timely and proper approvals, review, and controls are in place over bank and credit card reconciliations, cash receipts, and cash disbursements. Cause: There is a lack of procedures in place around these key accounting processes. Effect: A material misstatement in financial reporting could occur due to this deficiency. Recommendation: Processes and procedures should be implemented that ensure (1) timely invoicing under contracts, (2) proper completion and review of monthly bank and credit card reconciliations, and (3) proper controls related to processing, approval, and review of cash receipt and cash disbursement transactions. Views of Responsible Officials and Planned Corrective Actions: Basic Health International, Inc. agrees with the finding and has a plan in place to develop and implement procedures to correct the finding.

Categories

Reporting Material Weakness

Other Findings in this Audit

Programs in Audit

ALN Program Name Expenditures
93.393 Cancer Cause and Prevention Research $350,633
93.394 Cancer Detection and Diagnosis Research $183,203